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Abstract 
Background: In vivo imaging of orally administered lactic acid bacteria (LAB) and commensal bacteria in mice is 
shown to provide information on the spatial and temporal distribution of bacteria in the gastrointestinal tract. The 
bacteria can be detected and monitored using bioluminescence or near-infrared fluorescence.
Results: Fluorescence imaging of bacteria was established by expressing the infrared fluorescent protein IRFP713 in 
Lactococcus lactis, Lactobacillus plantarum and Escherichia coli. All three bacterial species were monitored in live mice 
and no major differences in transit time were observed. Bacteria passed through the stomach and small intestine in 
1 h and the majority were secreted from the large intestine after 6–8 h. Intestinal localization of bacteria was con-
firmed by imaging the isolated intestines and culturing the intestinal content. The use of fluorescence tomography for 
spatial localization of fluorescent bacteria has been established. The expression of an additional infrared fluorescent 
protein IRFP682 enabled concomitant detection of two bacterial populations in live mice.
Conclusions: The present work provides a methodological basis for future studies of probiotic and theranostic 
actions of LAB in mouse disease models.
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Background
In vivo optical imaging is a non-invasive method for spa-
tial and temporal monitoring of bacteria in live animals. 
It can provide data on bacterial dissemination in real 
time and enables better use of lower numbers of experi-
mental animals. In vivo imaging is of particular impor-
tance in the study of infectious diseases [1] and has been 
used to monitor the progression of infection with Salmo-
nella typhimurium, Pseudomonas aeruginosa, Strepto-
coccus pneumoniae and Listeria monocytogenes, etc. [1]. 
The majority of bacterial infection studies have been per-
formed using bioluminescence, requiring the expression 
of luciferase, an enzyme that is often of bacterial origin 
(e.g. from Vibrio spp.) [1]. An alternative to biolumines-
cence is fluorescence. The latter requires an external light 
source, involves lower sensitivity and lower signal-to-
noise ratio due to tissue autofluorescence. On the other 
hand, the fluorescence also has several advantages in 
comparison to bioluminescence: it does not require the 
administration of luciferin (which is time consuming and 
expensive), yields brighter signal and therefore requires 
shorter exposure times, and is more appropriate for com-
bining with single-cell in vitro assays such as microscopy 
or flow cytometry [2–4]. Tissue autofluorescence is mini-
mal in the near infrared region between 700 and 1000 nm 
[5]. Although this spectral range is covered by organic 
fluorescent probes [6], they require an appropriate label-
ling technique and are less suitable for bacteria since they 
are diluted with cell division. Infrared fluorescent pro-
teins (IFP1.4 [7] and IRFP [8]) with absorption and emis-
sion maxima in the near infrared region have recently 
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been developed and expressed constitutively in bacteria. 
IFP1.4 has been obtained by mutagenesis of bacteriophy-
tochrome DrBphD from Deinococcus radiodurans [7], 
and IRFP by mutagenesis of RpBphP2 from Rhodopseu-
domonas palustris [8]. Both fluorescent proteins require 
heme catabolic product biliverdin as a covalently-bound 
exogenous chromophore [8]. IRFP (aka IRFP713; Gen-
Bank accession number AEL88490) has excitation/emis-
sion maxima at 690/713  nm. Additional mutagenesis of 
IRFP yielded new variants with slightly different spec-
tral properties, including IRFP682 (GenBank accession 
number AGN32864) with excitation/emission maxima at 
663/682 nm [9]. Spectra of two proteins overlap; however 
they can be distinguished in  vivo by spectral unmixing 
[9].
Lactic acid bacteria (LAB) are used routinely in the 
food industry and have an excellent safety record. LAB, 
particularly Lactobacillus spp. and Bifidobacterium 
spp., are also gaining importance in therapy as probiot-
ics, due to their beneficial health effects [10–12]. Their 
intrinsic probiotic activity can be improved by the use 
of genetic engineering [13]. Genetically modified probi-
otic LAB can serve as vectors for local delivery of bio-
logically active molecules to the gastrointestinal tract 
or other mucosal surfaces, facilitating rational targeting 
of pathology-related molecules [14–17]. The ability to 
track probiotic, as well as commensal bacteria such as 
E. coli, in the digestive tract of live animals would pro-
vide valuable insights of probiotic action and their inter-
action with commensal bacteria. Daniel et  al. [18] have 
expressed luciferases of different origins in Lactobacillus 
plantarum and Lactococcus lactis in order to study bac-
terial persistence and precise localization in the intes-
tine. They have shown luciferase from beetle Pyrophorus 
plagiophthalamus to be the most appropriate for in vivo 
imaging.
Several fluorescent proteins, including GFP and 
mCherry, have been expressed in LAB and used for the 
study of intestinal tract colonization in mouse, chicken 
and zebrafish [19–23]. However, due to shorter excitation 
and emission wavelengths of the fluorophores that over-
lap with high haemoglobin absorption and strong tissue 
autofluorescence, the animals had to be euthanized and 
their organs examined ex vivo.
We report the expression of IRFP in prototype LAB L. 
lactis and Lb. plantarum, and in prototype commensal/
pathogen bacterium E. coli to monitor and compare the 
bacteria in vivo in mice by the use of fluorescence. Differ-
ent imaging modalities that are supported by IVIS Spec-
trum in vivo imager were tested. Expression of IRFP713 
and IRFP682 allowed simultaneous detection of two dif-
ferent bacteria in a single animal by using the spectral 
unmixing algorithm.
The current work aims at establishing an effective 
in  vivo fluorescence imaging platform for beneficial 
bacteria. In vivo imaging is expected to be one of the 
crucial research tools in future probiotic studies, by ena-
bling spatiotemporal monitoring of probiotic bacteria, 
their interaction with the immune system and with both 
commensal and pathogenic bacteria. The ability to con-
currently track different bacterial species will be of the 
greatest importance for the latter.
Results
Construction of infrared fluorescent L. lactis, Lb. plantarum 
and E. coli
Irfp713 open reading frame was cloned into different 
expression vectors for the expression of IRFP713 in dif-
ferent hosts. Irfp713 was expressed under the control of 
PnisA promoter from pNZ-IRFP713 plasmid in L. lactis 
NZ9000 that contains genomic copies of nisRK genes and 
enables induction with nisin [24]. The fluorescence inten-
sity of IRFP713-expressing L. lactis was much higher 
than that of the background fluorescence of uninduced 
culture, vehicle control culture (containing plasmid with-
out irfp713 ), or growth medium; the fluorescence inten-
sities of the latter three were almost the same (Fig.  1a). 
Initial drop in fluorescence intensity from 43,000 to 
25,000 FU was noted during 2 days of storage. However, 
after the initial drop of the fluorescence of the L. lactis 
culture, the latter remained relatively stable over the 
course of 42 days at 4 °C. High bacterial viability was enu-
merated during the first 14  days of storage (Additional 
file  1: Figure S1). In comparison to L. lactis, constitu-
tive expression of irfp713 (loss of responsiveness to nisin 
induction; Fig.  1b) was noted in Lb. plantarum, which 
was attributed to the introduction of nisRK genes into the 
backbone of pNZ-IRFP713 [25, 26]. In E. coli, irfp713 was 
expressed under the control of constitutive CP25 pro-
moter in pGEM::CP25-IRFP713 plasmid [27]. IRFP713 
was successfully produced in all three expression hosts, 
albeit different normalized fluorescence intensities to 
the cell concentration were observed (Fig. 2a). The high-
est normalized fluorescence intensity was detected in L. 
lactis, followed by Lb. plantarum and E. coli, respectively 
(Fig. 2a). Fluorescence of the IRFP713-expressing L. lac-
tis, Lb. plantarum and E. coli cultures increased linearly 
with increasing numbers of cells (Fig. 2b). Significant dif-
ferences in fluorescence were observed over a broad bac-
terial concentration range (OD600 = 0.075–30.0), yielding 
a linear line on a log–log graph (Fig. 2b) with correlation 
coefficients exceeding 0.95 for Lb. plantarum and 0.99 
for L. lactis and E. coli, respectively.
Irfp682 gene was prepared by site-directed mutagen-
esis of the irfp713 gene [27] and expressed in L. lactis 
NZ9000, as reported for the irfp713 gene. Fluorescence 
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intensities of the bacterial cultures expressing IRFP682 
and IRFP713 were recorded at emission/excitation 
wavelengths 663/682  nm (optimal for IRFP682) and 
690/713 nm (optimal for IRFP713; Fig. 3a). As expected, 
IRFP682-expressing bacteria yielded stronger fluores-
cence intensity at 663/682  nm and IRFP713-express-
ing bacteria at 690/713  nm. The absolute fluorescence 
intensities of the two IRFP-expressing bacterial popula-
tions at their respective optimal excitation and emis-
sion wavelengths were similar. Spectral overlap was 
observed as reported [9], fluorescence of both proteins 
being observed at both emission/excitation wavelengths. 
The fluorescence intensity of IRFP682-expressing bac-
teria at 690/713  nm was significantly higher than that 
of the control; however, it was threefold lower than that 
at 663/682  nm. Similarly, the fluorescence intensity of 
IRFP713-expressing bacteria at 663/682  nm was sig-
nificantly higher than that of the control but lower than 
that of the IRFP682-expressing bacteria at 690/713  nm 
(Fig. 3a). The signals of IRFP682 and IRFP713-expressing 
bacteria dispensed in a microtiter plate could be com-
pletely separated with the IVIS Spectrum in vivo imager 
by guided spectral unmixing (Fig.  3b). The spectral 
properties of IRFP682- and IRFP713-expressing bacte-
ria have been determined (Fig. 3c–f) and had excitation 
and emission maxima in accordance with those reported 
[9], which confirms the identity of the respective pro-
teins. The control bacteria yielded almost no fluorescence 
and no excitation or emission maxima were observed 
(Fig. 3c–f).
Fig. 1 Fluorescence intensity of L. lactis (a) or Lb. plantarum (b) expressing IRFP713 in comparison to various controls. IRFP denotes pNZ-IRFP713 
(a) or pNZRK-IRFP713 plasmid (b). Biliverdin (BV) or nisin (NIS) were added where noted (+). 8148 pNZ8148 empty vehicle control (without irfp713 
gene), GM17 M17 medium supplemented with glucose, MRS De Man, Rogosa and Sharpe medium
Fig. 2 Fluorescence intensity of L. lactis (LAC; red), Lb. plantarum (PLA; blue) and E. coli (ECO; green) expressing IRFP713. a Fluorescence intensity 
was normalized to OD600 = 1.0. Growth media of corresponding bacteria (GM17 M17 medium with 0.5 % glucose, LB lysogeny broth, MRS De Man, 
Rogosa and Sharpe medium) were used as negative controls. b Fluorescence intensity of bacterial cells as a function of optical density (cell concen-
tration). Correlation coefficients (R2) for individual curves are depicted in corresponding colors. FU fluorescence units, OD600 optical density
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In vivo reflectance (epifluorescence) time‑course 
imaging of mice following oral administration 
of IRFP713‑expressing bacteria
Three mice were administered 5.0  ×  1010 IRFP713-
expressing L. lactis cells to determine the time profile of 
the IRFP713 signal following oral administration of bac-
teria (Fig. 4). The IRFP713 signal at a given time point was 
reconstituted from a sequence of nine images recorded 
with different filter pair combinations using spectral 
unmixing (Additional file  2: Figure S2). Localization of 
Fig. 3 Evaluation of the expression of IRFP682 and IRFP713 in L. lactis. a Fluorescence intensity of L. lactis expressing IRFP682, IRFP713 and growth 
medium (GM17) determined at excitation/emission wavelengths 663/682 nm (white) or 690/713 nm (gray). b Distinction of IRFP682 and IRFP713-
expressing lactococci, dispensed in microtiter plates, with IVIS Spectrum and spectral unmixing (Contr. empty vehicle control, UMX1 IRFP682 
fluorescence, UMX2 IRF713 fluorescence, COMP. composite image). Emission (c, d) and excitation (e, f) spectra of IRFP682-expressing L. lactis (red), 
IRFP713-expressing L. lactis (blue) and control L. lactis (black), recorded at wavelengths specified in gray. Gray belts denote excitation and emission 
wavelengths at which reliable read-outs could not be obtained due to the vicinity of the wavelength used to record the spectrum
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the bacterial mass changed over time and was similar in 
all three mice (Fig. 4a). Radiant efficiency achieved maxi-
mum level (9.86 × 109–9.56 × 109) between 30 min and 
1 h after the administration. It then decreased gradually 
over the course of 24 h, indicating secretion and bacterial 
dilution along the entire volume of the intestinal tract. 
After 8  h, only weak radiant efficiency was observed in 
two mice (2.27 × 108), and after 12 h in only one mouse. 
After 24 h no fluorescence was observed, indicating elim-
ination of the L. lactis bacteria from the intestine (Fig. 4).
To visualize the dynamics of the bacterial mass dur-
ing the first hour after administration, a time course 
was recorded at 5–10  min intervals following adminis-
tration of 5.0 ×  1010 cells of IRFP713-expressing L. lac-
tis, E. coli and Lb. plantarum (Fig. 5). All three bacterial 
species were readily detected in mice although the aver-
age radiant efficiency was different between the species 
(1.3 × 108 E. coli, 1.9 × 109 Lb. plantarum, 4.6 × 109 L. 
lactis), due to the differences in normalized fluorescence 
observed between the different bacterial cells (Fig. 1). The 
exception was E. coli that yielded a fivefold lower signal 
than expected. The fluorescence intensity for a particular 
species remained relatively constant during the 1 h time 
course; although differences in localization of bacterial 
mass were readily observed.
Ex vivo epifluorescence time‑course imaging 
of mouse intestine following oral administration 
of IRFP713‑expressing bacteria
The passage of 5.0  ×  1010 cells of IRFP713-expressing 
L. lactis through individual parts of the intestine (stom-
ach, small intestine, caecum, large intestine) as a func-
tion of time was determined by removing their intestines 
at specified time points and epifluorescence imaging 
(Fig. 6a). Bacteria were quantified by determining radiant 
efficiencies in individual parts of the intestine (Fig.  6b). 
Radiant efficiencies correlated with the number of via-
ble bacteria (CFU/cm2) isolated from different parts 
of the intestine (Fig.  6c) at corresponding time points. 
The strongest correlation was calculated for caecum 
(R2 = 0.970) and large intestine (R2 = 0.951), but lower 
for stomach (R2 = 0.622) and small intestine (R2 = 0.819). 
Bacterial boluses were detected in the stomach and in 
the small intestine 5 min after administration. In the first 
60  min bacteria passed through the small intestine and 
reached the caecum. They were retained in the caecum 
for several hours; from there they gradually cleared to the 
large intestine from which more than 90 % were secreted 
in 10 h, as observed by the decrease in both, CFU num-
ber and radiant efficiency (Fig. 6b, c).
Mice were also administered with 5.0  ×  1010 cells of 
IRFP713-expressing E. coli and Lb. plantarum. Simi-
lar profiles of intestinal transit as with L. lactis were 
observed in isolated intestine for both Lb. plantarum 
(Fig. 7a) and E. coli (Fig. 7b). However, the E. coli signal 
diminished 4  h after administration, indicating faster 
secretion or lower intensity of the E. coli signal, which 
was further weakened by bacterial dilution.
Time‑course fluorescence tomography imaging 
of IRFP713‑expressing bacteria
Eleven mice were administered with 5.0 ×  1010 cells of 
IRFP713-expressing L. lactis and euthanized at defined 
time points over the course of 24 h. Fluorescence imaging 
tomography (FLIT) images of intact mice were recorded 
at each time point, using trans-illumination, and com-
pared with the epifluorescence images of intact mice, 
images of mice with open abdominal cavity, and with the 
Fig. 4 Time-course (24 h) imaging of mice administered with 5.0 × 1010 cells of IRFP713-expressing L. lactis. a Reflectance (epifluorescence) image 
with a color bar indicating radiant efficiency [(p/s/cm2/sr)/(μW/cm2)]. b Radiant efficiency of IRFP713-expressing L. lactis in mice as a function of 
time. Vertical bars indicate standard error
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epifluorescence images of isolated intestines. Very good 
correlation of spatial distribution of bacterial mass was 
observed in the first 3  h after administration between 
FLIT images, epifluorescence images and epifluorescence 
images of mice with open abdominal cavity (Fig. 8). Pre-
cise localization of bacterial mass could be determined 
using isolated intestine. Clear spatial separation between 
stomach (5  min), small intestine (20, 40  min), caecum 
(60  min) and large intestine (1.5, 2  h) was observed. 
The radiant efficiencies of the intestines decreased over 
time due to the considerable secretion, from 4.37 × 109 
to 5.85  ×  109 during the first hour, to 1.13  ×  108–
2.84 ×  108 in the period of 3–6  h after administration, 
and 5.54 × 106–9.24 × 106 in the period of 8–12 h after 
administration.
Differentiation between IRFP682 and IRFP713‑expressing 
bacteria in vivo and in isolated intestine
To verify the differentiation between IRFP682 and 
IRFP713-expressing bacteria in  vivo, mice were admin-
istered with 5.0 ×  1010 cells of IRFP682- and IRFP713-
expressing L. lactis. Spectral unmixing was used to 
distinguish the fluorescence of IRFP682, IRFP713 and 
background tissue autofluorescence (Additional file  3: 
Figure S3). Fluorescence of both IRFP-expressing bacte-
rial species in the separate mice was detected and differ-
entiated by spectral unmixing 5 min after administration 
(Fig.  9a). After 2  h, the mouse previously administered 
with IRFP682-expressing bacteria was further adminis-
tered with 5.0 × 1010 cells of IRFP713-expressing bacte-
ria. Signals of both bacterial species were detected and 
separated in a single mouse (Fig.  9b; middle mouse). In 
a separate experiment, the two bacterial species could 
also be differentiated in the intestine of the mouse that 
was administered with both bacterial species. Immedi-
ately following the administration of IRFP713-expressing 
bacteria, they were detected only in the stomach and at 
the beginning of the small intestine. IRFP682-expressing 
bacteria that were administered 2 h earlier, on the other 
hand, had already reached the caecum and large intes-
tine, but were also still present in the stomach (Fig. 9c).
Discussion
IRFP713 has been expressed in three bacterial hosts, 
two LAB (L. lactis, Lb. plantarum) and model com-
mensal/pathogenic bacterium E. coli, via inducible or 
constitutive expression system. The identity of IRFP713 
was confirmed by determining the spectral properties; 
these corresponded to those determined previously [8]. 
IRFP713 was codon-optimized for L. lactis and therefore 
optimally suited for expression in this organism, as con-
firmed by the highest normalized fluorescence intensity. 
The fluorescence intensity of the IRFP713-expressing cell 
culture correlated with the optical density (cell concen-
tration), and can be used for bacterial quantification [27, 
28]. A linear relationship between the fluorescence inten-
sity and the cell concentration was observed in cultures 
of all three bacterial species over a broad range of bac-
terial concentrations, facilitating precise quantification 
of bacteria in the culture. The background fluorescence 
of control bacteria was very low and did not differ from 
that of the growth medium. The fluorescence intensity of 
the IRFP713-expressing L. lactis culture and viability of 
the bacteria were shown to persist for much longer (50 
Fig. 5 Representative time-course (1 h) imaging of mice receiving 5.0 × 1010 cells of IRFP713-expressing L. lactis (upper row), Lb. plantarum (middle 
row) and E. coli (bottom row). Color bars indicate radiant efficiency [(p/s/cm2/sr)/(μW/cm2)]
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and 14 days, respectively) than the period of the animal 
experiments (maximum 24  h). This allows the assump-
tion that the gradual decrease in fluorescence in ani-
mal experiments (described below) is due to bacterial 
secretion and not to IRFP713 degradation or bacterial 
cell lysis. The fluorescence is not necessarily related to 
viable bacteria [27]; however free IRFPs would probably 
be degraded or denatured under intestinal conditions. 
Intestinal bacterial viability was confirmed by successful 
isolation of the bacteria from different parts of the mouse 
intestine.
IRFP713 enables excitation/emission in the near-infra-
red region (690/713  nm), which should minimize the 
autofluorescence of background tissue. In practice, how-
ever, the autofluorescence in this spectral range was still 
considerable and prevented exact localization of the sig-
nal source and estimation of its strength. This was partly 
circumvented by the use of a chlorophyll-minimized 
(alfalfa-free) diet [29]. The fluorescence intensity could 
be further increased by using nude or shaved mice; how-
ever, this was not considered in the present research. The 
IRFP713 signal was readily distinguished from the back-
ground by using spectral unmixing in reflectance (epif-
luorescence) imaging.
Different imaging modalities were employed to moni-
tor the fate of the bacteria after administration to mice. 
Epifluorescence imaging is straightforward and fast. 
However, quantification of the fluorescence signal is lim-
ited, as it depends on both the fluorescence intensity of 
the source and its depth inside the animal body (distance 
from the surface) [4]. While the ratio of fluorescence of 
IRFP713-expressing L. lactis and Lb. plantarum meas-
ured in  vivo corresponded to that determined in  vitro, 
the fluorescence intensity of IRFP713-expressing E. 
coli was lower. Epifluorescence imaging of three mice 
that were administered simultaneously with IRFP713-
expressing L. lactis resulted in considerable standard 
errors. Nevertheless, the time dependent decrease in 
fluorescent signal caused by bacterial secretion was in 
agreement with other approaches that were used (ex 
vivo imaging of intestines, fluorescence tomography). 
Epifluorescence imaging was used primarily for qualita-
tive localization of the signal source, rather than source 
quantification. When comparing epifluorescence images 
of intact animals with those of mice with open abdomi-
nal cavities, or with tomographic images, considerable 
agreement was observed. However, despite effective 
separation of IRFP713 fluorescence from the tissue auto-
fluorescence, reconstruction of the exact position of the 
source of the signal and its annotation to a specific organ 
is difficult. During the first hour after administration of 
different bacterial species, when the bacteria traverse the 
small intestine (discussed below) the movements of the 
bacterial mass could be observed, but reconstitution of 
its positioning in the small intestine was limited. Annota-
tion of the source of the signal to a specific organ could 
be improved by the use of computed tomography scan.
Exact positioning of all three species of fluorescent 
bacteria was achieved by epifluorescence ex  vivo imag-
ing of isolated intestines, in which the tissue thickness 
is minimal. The quantification achieved by measuring 
Fig. 6 Transit and survival of IRFP713-expressing L. lactis in mice. 
Mice were administered with 5.0 × 1010 cells. Intestines were 
extracted at different time points and recorded by epifluorescence 
imaging (a). Radiant efficiencies [(p/sec/cm2/sr)/(μW/cm2); b] and 
numbers of viable bacteria (CFU/cm2; c) were determined in different 
parts of the intestine as a function of time. Stomach is shown in red, 
small intestine in blue, caecum in green, and large intestine in brown
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radiant efficiencies in different parts of the intestine was 
verified by isolating and determining the count of viable 
bacteria in the corresponding intestinal parts. Good cor-
relations were observed for caecum and large intestine, 
and somewhat lower correlations for stomach and small 
intestine, probably due to faster transit through the latter 
two organs. However, ex vivo imaging is an approach that 
only partially fulfils the aim of the present study, namely 
in vivo imaging.
To resolve the exact positioning of the bacteria in the 
whole animal fluorescence tomography (FLIT), that 
requires transillumination fluorescence measurements, 
was applied. FLIT enabled spatial reconstruction of 
IRFP713-expressing bacteria at given time points. Due to 
the complexity, spectral unmixing combined with FLIT 
is not feasible in time-course experiments and was not 
employed. Nevertheless, comparison of FLIT with epi-
fluorescence images of whole animals and animals with 
an open abdominal cavity revealed very good agreement 
between different imaging techniques. This suggests that 
the FLIT technique is suitable for in vivo monitoring of 
IRFP-expressing bacteria.
All imaging modalities were employed for determin-
ing the time-course of transit of three bacterial species in 
live mice in a 24 h time window. The results of epifluo-
rescence imaging of live mice, tomographic (FLIT) imag-
ing, ex vivo epifluorescence imaging of isolated intestines 
and culturing of the bacteria from different parts of the 
intestine were in agreement. To summarize, bacterial 
mass reached the stomach immediately after administra-
tion. After approximately 1  h, bacteria passed through 
the small intestine and reached the caecum. In some 
experiments longer bacterial retention in the stomach 
was observed, possibly due to inter-animal differences in 
feeding prior to administration, or to coprophagy. From 
the caecum the bacteria entered the large intestine and 
were gradually secreted from the organism. Bacteria 
were barely detectable 6–8  h after the administration, 
using imaging techniques, due to considerable secre-
tion and dilution, and were no longer detected after 
24 h. The observed intestinal transit data correspond to 
those reported [29]. No major differences were observed 
between different bacterial species, as inferred from the 
ex  vivo epifluorescence imaging of isolated intestines. 
Fig. 7 Ex vivo imaging of mouse intestines extracted at different time points after administration of 5.0 × 1010 cells of IRFP713-expressing Lb. plan-
tarum (a) and E. coli (b). Color bars indicate radiant efficiency [(p/s/cm2/sr)/(μW/cm2)]
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However, the differences in normalized fluorescence 
intensity between bacterial species somewhat hindered 
comparison of transit times. This was particularly evident 
with E. coli that had the lowest normalized fluorescence 
and therefore resulted in the apparently fastest clearance 
from the organism.
One of the potential advantages of in vivo fluorescence 
imaging is the concomitant monitoring of multiple fluo-
rescent proteins with different spectral properties. A pal-
ette of different IRFPs has recently been introduced [9]. 
The gene for the IRFP variant IRFP682 was obtained by 
site-directed mutagenesis and expressed in L. lactis. Its 
identity was confirmed by spectral properties in the bacte-
rial culture that corresponded to those reported previously 
[8]. The considerable spectral overlap of IRFP682 and 
IRFP713 prevents distinguishing them with FLIT. On the 
other hand, the epifluorescence signals of IRFP682 and 
IRFP713 can be distinguished from each other by spectral 
unmixing. A population of L. lactis expressing IRFP713 
was distinguished from one expressing IRFP682 in vivo in 
mice and ex vivo in isolated intestine. However, it should 
be noted that the two bacterial species can be more effec-
tively resolved by spectral unmixing if they are sufficiently 
separated spatially. The fluorescence signal is less reliably 
unmixed if there is a significant bacterial overlap (e.g., bac-
terial mixture in a single organ). The resolution of bacterial 
populations could be further improved by using photoa-
coustic tomography [30].
Fig. 8 Imaging of mice at different time points after administration with 5.0 × 1010 cells of IRFP713-expressing L. lactis. Whole-body imaging was 
performed using trans-illumination and fluorescence imaging tomography (FLIT; a on the back, b on the side); or c epifluorescence. Ex vivo epifluo-
rescence imaging was performed on dissected animals (d) or isolated intestines (e). Color bars indicate radiant efficiency [(p/s/cm2/sr)/(μW/cm2); 
epifluorescence] or total fluorescence yield (pmol/M cm; FLIT)
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Conclusions
The feasibility of using fluorescence for in vivo monitor-
ing of LAB in mice has been demonstrated in the present 
work. Near-infrared fluorescent protein IRFP713 was 
expressed in two LAB species (L. lactis, Lb. plantarum) 
and in a model commensal/pathogen bacterium, E. coli, 
and was detected directly in a bacterial culture without 
the need for removal of the growth medium, indicating 
its potential as a reporter protein in various bacteria. 
All three bacterial species were imaged in live mice with 
IVIS Spectrum, using fluorescence reflectance imaging 
(epifluorescence) or fluorescence tomography. The data 
were supplemented by epifluorescence imaging of iso-
lated intestines ex  vivo. The ability to monitor the gas-
trointestinal transit time of bacteria was demonstrated, 
as well as their spatial localization. Viable bacteria were 
isolated and cultured from different parts of the intes-
tine and their quantity corresponded to the fluorescence 
signal determined by imaging. Two IRFPs, differing in 
their spectral properties, were expressed in L. lactis. 
Populations of bacteria expressing IRFP713 and IRFP682 
were distinguished in  vivo, enabling their concomitant 
monitoring. A platform for future studies of probiotic 
and theranostic effects of LAB in mouse disease models, 
as well as their interaction with commensal or pathogenic 
bacteria, has thus been established.
Methods
Bacterial strains, media and culture conditions
The bacterial strains used in this study are listed in 
Table  1. L. lactis NZ9000 was grown at 30  °C in M-17 
medium (Merck) supplemented with 0.5 % glucose (GM-
17) and 10  µg/mL chloramphenicol without aeration. 
Lactobacillus plantarum ATCC 8014 was grown at 37 °C 
in De Man, Rogosa and Sharpe (MRS) medium (Merck) 
supplemented with 10  µg/mL chloramphenicol, without 
aeration. E. coli DH5α was grown at 37 °C with aeration 
in lysogeny broth (LB) supplemented with 100  µg/mL 
ampicillin. Media were supplemented with 15.5  µg/mL 
biliverdin HCl (Sigma Aldrich).
Fig. 9 Concomitant imaging of two bacterial populations. a In vivo imaging 5 min after administration of 5.0 × 1010 cells of IRFP682-expressing L. 
lactis (middle mouse) and 5.0 × 1010 cells of IRFP713-expressing L. lactis (right mouse). Control mouse (left) received no bacteria. b In vivo imag-
ing of mice 2 h after administration. The middle mouse was administered with an additional dose of 5.0 × 1010 cells of IRFP713-expressing L. lactis 
immediately prior to the imaging. c Ex vivo image of mouse intestine from a separate experiment. Left control mouse. Right mouse administered 
with IRFP682- and, after 2 h, IRFP-713-expressing L. lactis. AF tissue autofluorescence, UMX1 IRFP682 fluorescence, UMX2 IRFP713 fluorescence, COMP. 
composite image. Color bar indicates radiant efficiency [(p/sec/cm2/sr)/(μW/cm2)]
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Bacterial viability
The number of colony forming units (CFU)/cm2 was 
determined by using the drop-plate method [31]. Long 
term stationary culture viability was determined by plat-
ing tenfold dilutions without antibiotic. To determine 
CFU/cm2 in different parts of the intestine the contents 
of stomach, small intestine, caecum and large intestine 
were aseptically squeezed out and resuspended in 500 
µL PBS, vortexed vigorously and briefly centrifuged (4 s 
spin). Ten-fold dilutions of the supernatant were plated 
on chloramphenicol-containing GM-17 plates using the 
drop-plate method [31]. The CFU/cm2 was normalized to 
the weight of the intestinal content.
IRFP cloning
The IRFP amino acid sequence [8] was back-translated 
and codon-optimized for L. lactis, yielding irfp713 
gene, which was obtained from Geneart (Table  1). The 
gene was cloned to pNZ8148, pMSP3545 and pNZRK 
via NcoI/XbaI sites. pNZRK was prepared by digest-
ing pNZ8148 with SalI, blunting and blunt-end ligation 
with nisRK PCR amplicon. The latter was obtained by 
Table 1 Strains, plasmids, gene and primers
Bacteria, plasmid, or gene Relevant features or sequence (5′–3′) References or 
sources
Bacteria
 E. coli DH5α endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR F- Φ80dlacZΔM15 Δ(lacZYA-argF)U169,  
hsdR17(rK- mK +), λ–
Invitrogen
 L. lactis NZ9000 MG1363 nisRK ΔpepN NIZO [35, 36]
 Lb. plantarum ATCC 8014 Wild type ATCC
Plasmid
 pNZ8148 pSH71 derivative, PnisA, CmR, nisin-controlled expression NIZO [35, 36]
 pNZRK pNZ8148 containing nisR and nisK genes This work
 pNZ-IRFP713 pNZ8148 containing irfp713 gene This work
 pNZ-IRFP682 pNZ8148 containing irfp682 gene This work
 pNZRK-IRFP713 pNZ8148 containing irfp713, nisR and nisK genes This work
 pMA-T-IRFP713 pMA-T containing irfp713 gene This work
 pMSP3545 Emr, PnisA, nisRK, NcoI for translational fusion, ColE1 and pAMβ1 replicons [37]
 pMSP3545-IRFP713 pMSP3545 containing irfp713 gene This work
 pGEM::CP25-IRFP pGEM-T Easy containing irfp713 gene under the control of CP25 promoter [27]
Gene

















 nisR-F GATGATAAGCTGTCCAAAC This work
 nisK-R TTTAGGATAACTTCTGCCC This work
 682-1F CTCAGACTTTTCTGGTGTAGTAATCGCAGAGGATAG This work
 682-2F GCATTATCCTGCCAGTGCTGTTCCAGCCCAAGC This work
 682-3F CCATCTTACGATCTGTTTCACCTTGTCATTTAGAGTTTATGCG This work
 682-1R CTATCCTCTGCGATTACTACACCAGAAAAGTCTGAG This work
 682-2R GCTTGGGCTGGAACAGCACTGGCAGGATAATGC This work
 682-3R CGCATAAACTCTAAATGACAAGGTGAAACAGATCGTAAGATGG This work
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using nisR-F/nisK-R primer pair on pMSP3545 template. 
pNZRK was prepared for the use of PnisA promoter in 
Lb. plantarum ATCC 8014, because its genome does not 
contain nisRK genes. pMA-T-IRFP713 was used as a tem-
plate to introduce mutations E180V, T202A and V254C 
by using QuikChange II Site-Directed Mutagenesis Kit 
(Stratagene). Primer pairs 682-1F/682-1R, 682-2F/682-
2R and 682-3F/682-3R were used sequentially to obtain 
irfp682 gene [8]. All plasmids were verified by nucleo-
tide sequencing performed by GATC Biotech (Ger-
many). KOD polymerase was used for PCR amplification. 
Restriction enzymes were from New England Biolabs and 
Fermentas. L. lactis and Lb. plantarum were transformed 
according to Holo [32] and Berthier [33], respectively, 
with electroporation, using Gene Pulser II apparatus 
(Biorad). E. coli was transformed with heat-shock.
Expression of IRFP variants
Overnight cultures of bacteria harboring appropriate 
plasmids were diluted (1:100) in fresh medium and grown 
to optical density (OD600) 2.50–3.00. Required exogenous 
chromophore biliverdin was provided in bacterial growth 
medium when culturing bacteria for both in  vitro and 
in vivo experiments. L. lactis cultures were induced with 
25 ng/mL nisin (Fluka) at OD600 = 0.80 and incubated for 
a further 3 h; no induction was necessary for Lactobacil-
lus and Escherichia cultures. Bacterial cultures were cen-
trifuged at 5000g, resuspended in an appropriate volume 
of 10  % w/v sucrose solution and stored at 4  °C before 
administration.
Measurement of IRFP fluorescence in bacterial cultures
Aliquots of cell cultures (200  µl) were transferred to 
black, flat-bottom 96-well plates (Greiner). Fluorescence 
was measured on an Infinite M1000 microplate reader 
(Tecan) [27], with excitation/emission at 690/713  nm 
for IRFP713, or 663/682  nm for IRFP682. Fluorescence 
intensity was normalized to a cell density OD600 =  1.0. 
Excitation and emission spectra were recorded between 
600 and 800  nm at 2  nm intervals, using the appropri-
ate excitation and emission maxima (663/682  nm for 
IRFP682; 690/713  nm for IRFP713). All the measure-
ments were made in triplicate.
Imaging of IRFP‑expressing bacteria in vivo in mice
Fifty 8  week-old FVB mice were bred in the animal 
facility at the Jozef Stefan Institute. They were housed 
in pathogen-free conditions, with food and water 
ad  libitum. Alfalfa-free Teklad global rodent diet 2016 
was used to minimize background intestinal fluores-
cence [34] at least 4  days before the start of experi-
ments. Maximum volumes of 200  μL of bacteria were 
administered by oral gavage. Bacteria were kept at 
4 °C for 2 days prior to administration to ensure stable 
fluorescence.
An IVIS Spectrum in vivo imaging system (PerkinElmer) 
was used for fluorescence imaging of mice. Mice were 
anesthetized with isoflurane (Forane). Spectral unmix-
ing of IRFP713 and background fluorescence signals was 
performed by recording sequences of images using the 
following excitation/emission filter pairs: 675/720  nm, 
675/740  nm, 675/760  nm, 605/660  nm, 605/680  nm, 
605/700  nm, 605/720  nm, 605/740  nm and 605/760  nm. 
Spectral unmixing of IRFP682, IRFP713 and background 
fluorescence signals was performed by recording a 
sequence of images using the following excitation/emis-
sion filter pairs: 640/680  nm, 640/700  nm, 640/720  nm, 
640/740  nm, 640/760  nm, 640/780  nm, 675/720  nm, 
675/740  nm, 675/760  nm, 605/660  nm, 605/680  nm, 
605/700  nm, 605/720  nm, 605/740  nm and 605/760  nm. 
Instrument background fluorescence was removed by 
using the adaptive fluorescence background subtraction 
tool. Exposure time was adjusted to obtain count num-
bers between 600 and 60,000. The region of interest (ROI) 
was set manually and radiant efficiency (photons s−1 cm−2 
steradian−1  per  μW  cm−2) was determined when appro-
priate. Fluorescence tomography (FLIT) was performed by 
recording a trans-illumination sequence of eight images. 
Images were analyzed using Living Image, version 4.3.1.
When required, mice were euthanized by cervical dis-
location. This was followed by exposure of the abdomi-
nal cavity and removal of the intestine from stomach to 
rectum.
Ethics statement
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Additional files
Additional file 1: Figure S1. Time-dependent viability (A) and stability of 
IRFP713 fluorescence (B) of the stationary phase L. lactis culture expressing 
IRFP713 (red), or empty vehicle control (without irfp713 gene; blue). The 
bacterial culture was stored at 4°C for 56 days.
Additional file 2: Figure S2. Representative example of spectral unmix-
ing of IRFP713 signal from background signal. A: collection of images 
recorded with different filter pair combinations (see Methods). B: unmixed 
background (left) and IRFP713 signal (right). Color bar indicates radiant 
efficiency.
Additional file 3: Figure S3. Representative example of spectral unmix-
ing of IRFP713, IRFP682 and background signal. A: A collection of images 
recorded with different filter pair combinations (see Methods). B: unmixed 
background (top), IRFP713 (bottom left) and IRFP682 signal (bottom right). 
Color bar indicates radiant efficiency.
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